UPXI Long Call Strategy
UPXI (Upexi, Inc.), in the Consumer Defensive sector, (Household & Personal Products industry), listed on NASDAQ.
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
UPXI (Upexi, Inc.) trades in the Consumer Defensive sector, specifically Household & Personal Products, with a market capitalization of approximately $60.5M, a beta of -0.24 versus the broader market, a 52-week range of 0.54-9.115, average daily share volume of 2.4M, a public-listing history dating back to 2021, approximately 59 full-time employees. These structural characteristics shape how UPXI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.24 indicates UPXI has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on UPXI?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
UPXI snapshot
As of August 14, 2026, spot at $0.75, ATM IV 155.46%, IV rank 30.94%, expected move 44.57%. The long call on UPXI below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this long call structure on UPXI specifically: UPXI IV at 155.46% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 44.57% (roughly $0.33 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated UPXI expiries trade a higher absolute premium for lower per-day decay. Position sizing on UPXI should anchor to the underlying notional of $0.75 per share and to the trader's directional view on UPXI stock.
UPXI long call setup
The UPXI long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With UPXI at $0.75 on that close, the first option leg uses a $0.75 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed UPXI chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 UPXI shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.75 | N/A |
UPXI long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
UPXI long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on UPXI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on UPXI
Long calls on UPXI express a bullish thesis with defined risk; traders use them ahead of UPXI catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
UPXI thesis for this long call
The market-implied 1-standard-deviation range for UPXI extends from approximately $0.42 on the downside to $1.08 on the upside. A UPXI long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current UPXI IV rank near 30.94% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on UPXI should anchor more to the directional view and the expected-move geometry. As a Consumer Defensive name, UPXI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to UPXI-specific events.
UPXI long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. UPXI positions also carry Consumer Defensive sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move UPXI alongside the broader basket even when UPXI-specific fundamentals are unchanged. Long-premium structures like a long call on UPXI are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current UPXI chain quotes before placing a trade.
Frequently asked questions
- What is a long call on UPXI?
- A long call on UPXI is the long call strategy applied to UPXI (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With UPXI stock at $0.75 on the most recent close, the strikes shown on this page are snapped to the nearest listed UPXI chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are UPXI long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the UPXI long call priced from the end-of-day chain at a 30-day expiry (ATM IV 155.46%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a UPXI long call?
- The breakeven for the UPXI long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The UPXI market-implied 1-standard-deviation expected move in the same options snapshot is approximately 44.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on UPXI?
- Long calls on UPXI express a bullish thesis with defined risk; traders use them ahead of UPXI catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current UPXI implied volatility affect this long call?
- UPXI ATM IV is at 155.46% with IV rank near 30.94%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.